Want to see KLYG full AI Analyst Report?
KLYG Stock Chart & Stats
$0.13
<$0.01(4.82%)
At close: 4:00 PM EDT
$0.13
<$0.01(4.82%)
Day’s Range― - ―
52-Week Range$0.07 - $0.30
Previous CloseN/A
Volume21.70K
Average Volume (3M)3.56K
Market Cap
$5.95M
Enterprise Value$8.29
Total Cash (Recent Filing)$96.94K
Total Debt (Recent Filing)$384.42K
Price to Earnings (P/E)―
Beta0.19
Next Earnings
Nov 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding50,123,430
10 Day Avg. Volume3,056
30 Day Avg. Volume3,559
Financial Highlights & Ratios
PEG Ratio0.49
Price to Book (P/B)7.17
Price to Sales (P/S)1.91
P/FCF Ratio-30.09
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthThe return to strong top-line growth indicates improved demand and market traction after the prior-year decline. If sustained, this expansion can support operating leverage, broaden the company’s revenue base, and provide a foundation for improving earnings over the next several quarters.
Gross MarginA gross margin near 77% points to attractive product economics and meaningful value capture in the business model. Maintaining this level would give the company more room to fund operations, absorb costs, and convert future revenue growth into stronger operating and net profitability.
Improved LeverageLower leverage reduces balance-sheet strain compared with the 2023 peak and preserves more financial flexibility. Positive equity provides a capital base for ongoing operations, while the improved debt-to-equity position may make it easier to manage obligations as profitability develops.
Bears Say
Persistent Net LossesThe company has not yet translated its revenue rebound and strong gross margin into consistent bottom-line earnings. Continued net losses can consume equity, restrict internally funded investment, and leave the business more exposed if operating improvement does not persist.
Weak Cash GenerationNegative operating and free cash flow indicate that reported business activity is not currently producing cash on a sustainable basis. This limits self-funding capacity and could require tighter spending or external financing if losses continue and working capital needs increase.
Volatile Cash FlowThe repeated swings between positive and negative cash generation show that cash conversion has not yet become dependable. Such volatility complicates planning, weakens confidence in recurring funding capacity, and increases execution risk even though the latest cash burn is modest in absolute dollars.
KLYG FAQ
What was Kelyniam Global Inc’s price range in the past 12 months?
Kelyniam Global Inc lowest stock price was $0.07 and its highest was $0.30 in the past 12 months.
What is Kelyniam Global Inc’s market cap?
Kelyniam Global Inc’s market cap is $5.95M.
When is Kelyniam Global Inc’s upcoming earnings report date?
Kelyniam Global Inc’s upcoming earnings report date is Nov 16, 2026 which is in 58 days.
How were Kelyniam Global Inc’s earnings last quarter?
Kelyniam Global Inc released its earnings results on Aug 11, 2026. The company reported -$0.002 earnings per share for the quarter.
Is Kelyniam Global Inc overvalued?
According to Wall Street analysts Kelyniam Global Inc’s price is currently Overvalued.
Does Kelyniam Global Inc pay dividends?
Kelyniam Global Inc does not currently pay dividends.
What is Kelyniam Global Inc’s EPS estimate?
Kelyniam Global Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kelyniam Global Inc have?
Kelyniam Global Inc has 50,123,430 shares outstanding.
What happened to Kelyniam Global Inc’s price movement after its last earnings report?
Kelyniam Global Inc reported an EPS of -$0.002 in its last earnings report. Following the earnings report the stock price went up 3.053%.
Which hedge fund is a major shareholder of Kelyniam Global Inc?
Currently, no hedge funds are holding shares in KLYG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kelyniam Global Inc
Kelyniam Global, Inc. operates as a medical device manufacturer, providing specialized solutions for patients. The company creates custom prosthetics using computer-aided design (CAD) and manufacturing (CAM) processes, employing advanced medical-grade polymers. Additionally, Kelyniam develops, produces, and supplies specific cranial and craniofacial fixation screws, crucial for the reconstruction of skull and facial structures. Its clientele encompasses health systems, hospitals, sales representatives, surgeons, insurance providers (payors), and individual patients. Established in 2005, the company was originally named Ketner Global Investments, Inc., rebranding to Kelyniam Global, Inc. in December 2007. Kelyniam Global is based in Collinsville, Connecticut.
Technical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors